Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700020282

Trial Profile

Clinical Trials Insight: 700020282

Phase of Trial: Phase I

Latest Information Update: 30 May 2009

At a glance

  • Drugs PX 12 (Primary)
  • Indications Gastric cancer; Intestinal cancer
  • Focus Therapeutic Use
  • Sponsors Oncothyreon
  • Most Recent Events

    • 30 May 2009 Final results have been presented at American Society of Clinical Oncology (ASCO) Annual Meeting, according to an Oncothyreon media release.
    • 30 May 2009 Status changed from active, no longer recruiting to completed. Final results have been presented.
    • 10 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top